Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from SMS Pharmaceuticals Limited ( (IN:SMSPHARMA) ) is now available.
SMS Pharmaceuticals Limited has announced that it has complied with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending December 31, 2024. This compliance highlights the company’s adherence to regulatory standards, which is crucial for maintaining its market credibility and ensuring seamless operations for stakeholders.
More about SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited operates within the pharmaceutical industry, focusing on the production of active pharmaceutical ingredients (APIs) and intermediates. The company is known for its commitment to quality and compliance, catering to both domestic and international markets.
YTD Price Performance: -13.89%
Average Trading Volume: 17,054
Current Market Cap: 18.81B INR
See more data about SMSPHARMA stock on TipRanks’ Stock Analysis page.